Global Genetically Modified Organisms Industry
The global genetic testing industry is expected to be worth $2.2 billion by 2017, according to research from Global Industry Analysts. Market growth is fuelled by awareness regarding the advantages of genetic testing. Developments in the sector are also driven by increasing cases of chronic diseases, rising numbers of patients suffering from cancer and an aging global population. The US dominates the global genetic testing industry.
The genetically modified organism industry involves the creation of new sets of genes for insertion into an organism. These organisms have many applications, including adaption of foods such as is the case with transgenic plants that have been modified to better survive pests and herbicides or to boost shelf-life and nutritional value. Other areas in which genetically modified organisms are used apart from agriculture include gene therapy, medical research and the manufacture of pharmaceuticals.
Key Market Segments
- The global gene amplification technology market is expected to reach $2.2 billion by 2017, reports Global Industry Analysts. The Human Genome Project greatly benefited the sector and, along with molecular diagnostics, continues to fuel market expansion. Gene amplification technology market growth is also being driven by an aging population and increases of age-related diseases. The US dominates the global market. Gene Amplification Technology touches on different life sciences disciplines, including diagnosis, drug discovery, forensic identification and molecular biology research. Polymerase Chain Reaction represents a significant segment in the field of gene amplification, recording strong growth over the past few years.
- The global synthetic biology market represents a leading discipline within biotechnology with many applications. BCC Research points to commercial opportunities for synthetic biology such as enzymes, specialty chemicals, biofuels, synthetic genes, chassis microorganisms and pharmaceuticals. Synthetic biology overlaps with other industry like chemicals, biotechnology, diagnostics, pharmaceuticals, chemicals and life science tools.
- Synthetic biology market growth is being fuelled by technological developments in DNA synthesis and sequencing, demand for renewable feedstock, bioinformatics and specialty media.
- The global industrial enzymes market reached close to $3.5 billion in 2010, according to research from BCC Research. The market is forecast to record yearly growth in excess of 5% over the coming years to hit almost $4.5 billion by 2015. Technical enzymes represent a leading market segment, expected to record yearly growth of almost 7%, with expected worth set to reach $1.5 billion in 2015. Technical enzyme sales were highest in the leather market, and second-highest in the bioethanol sector. The food and beverage enzyme market segment is forecast to record yearly growth in excess of 5% to reach $1.3 billion by 2015, up from under $1 billion in 2010. Milk and dairy recorded the highest sales in the food and beverage enzyme market, exceeding $400 million in 2009.
Industry Leaders
- Leading companies operating in the genetic engineering market include BioRad Laboratories, Transgenomic, Applied Biosystems, Roche Diagnostics, Abbott Laboratories, Celera, PerkinElmer, Roche Molecular Diagnostics, ELITech, Abbott Molecular, Quest Diagnostics and AutoGenomics.
- Leading companies operating in the gene amplification technology market include BioMérieux, Takara Bio, Abbott Laboratories, Cepheid, Becton, Rubicon Genomics, QIAGEN, Bio-Rad Laboratories, Roche Diagnostics, Dickinson and Company, and Life Technologies Corporation.
Market Outlook
The genetic testing sector is forecast to facilitate personalized medicine. Genetic testing will continue to play an important role in identifying the best cancer treatment for patients and in identifying unsuitable drugs for other specific patients, reports Global Industry Analysts. Genetic testing will continue to be used in diagnosis, having facilitated the diagnosis of diseases like sickle cell anemia, cystic fibrosis and hemophilia. Cancer genetic testing is forecast to record the highest growth, and is expected to dominate the overall market by 2017.
Leading Industry Associations
More »
